| Style | Citing Format |
|---|---|
| MLA | Esmalipour R, et al.. "Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study." DARU# Journal of Pharmaceutical Sciences, vol. 31, no. 2, 2023, pp. 173-182. |
| APA | Esmalipour R, Salari P, Ebadi A, Mehrdad N, Larijani B (2023). Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study. DARU# Journal of Pharmaceutical Sciences, 31(2), 173-182. |
| Chicago | Esmalipour R, Salari P, Ebadi A, Mehrdad N, Larijani B. "Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study." DARU# Journal of Pharmaceutical Sciences 31, no. 2 (2023): 173-182. |
| Harvard | Esmalipour R et al. (2023) 'Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study', DARU# Journal of Pharmaceutical Sciences, 31(2), pp. 173-182. |
| Vancouver | Esmalipour R, Salari P, Ebadi A, Mehrdad N, Larijani B. Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study. DARU# Journal of Pharmaceutical Sciences. 2023;31(2):173-182. |
| BibTex | @article{ author = {Esmalipour R and Salari P and Ebadi A and Mehrdad N and Larijani B}, title = {Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study}, journal = {DARU# Journal of Pharmaceutical Sciences}, volume = {31}, number = {2}, pages = {173-182}, year = {2023} } |
| RIS | TY - JOUR AU - Esmalipour R AU - Salari P AU - Ebadi A AU - Mehrdad N AU - Larijani B TI - Designing and Psychometric Evaluation of Pharmacists' Attitude Toward Ethical Challenges Questionnaire in Pharmacy Practice: A Mixed‑Method Study JO - DARU# Journal of Pharmaceutical Sciences VL - 31 IS - 2 SP - 173 EP - 182 PY - 2023 ER - |